Insulin Patch Pumps Market Size, Share & Trends Analysis Report By Delivery Mode (Basal, Bolus, Basal & Bolus), By Type, By Distribution Channel (Hospitals, Retail Pharmacies, Private Clinics, Online Pharmacies), And Segment Forecasts, 2020 - 2027

Report Overview

The global insulin patch pumps market size was valued at USD 768.5 million in 2019 and is expected to exhibit a CAGR of 10.9% during the forecast period. The high growth can primarily be attributed to factors such as the rising prevalence of diabetes and increasing awareness about advanced patch pumps. People with type 1 diabetes prefer insulin patch pumps, as they do not need to carry an insulin infusion set. Owing to higher convenience, patch pumps are preferred by older and working people.

In general, patch pumps are smaller than conventional insulin pumps and are more discrete and easier to use. Moreover, these pumps are more affordable as compared to conventional insulin delivery devices, which generates more demand. Patch pumps are attached to the skin using adhesive layer and due to the advanced technology, they require minimum monitoring. These pumps are usually integrated with blood glucose or a continuous glucose monitoring system.

Technological advancements and the use of artificial intelligence in this field are expected to play a significant role in replacing traditional insulin delivery devices. Increasing frequency of product launches along with collaborations between major players and technology developers is also expected to boost the market competition.

For instance, Tandem Diabetes Care is developing t:sport insulin pump, which will be half the size of its t: slim X2. Availability of custom-made patch pumps is expected to increase the popularity of these devices during the forecast period. Discrete nature of the devices is one of the major factors increasing their adoption in younger population.

The worldwide increasing incidence and prevalence of diabetes are expected to present lucrative opportunities for advanced diabetes management devices, including patch pumps. According to the International Diabetes Federation, the global diabetic population is expected to reach 700 million by 2045, which includes a significant number of older people. According to the United Nations report, in 2018, the global population aged 65 or above outnumbered children under 5. The population aged 80 years or over is projected to reach 426 million by 2050 from 143 million in 2019.

Delivery Mode Insights

Based on the delivery mode, the market is segmented into basal, bolus, and basal & bolus combination. Basal & bolus combination segment dominated the market in 2019 and is expected to maintain the same owing to the advanced features and availability of a wide variety of products. Basal & bolus therapy helps normalize blood sugar levels without increasing the risk of hypoglycemia. Moreover, basal and bolus therapy includes an injection after each meal, which emulates the activity of healthy pancreas. In addition, these therapies are used by both type 1 and type 2 diabetes patients, hence, dominated the market.

The basal insulin delivery mode segment also captured a significant share in 2019 and is anticipated to grow at a rapid pace. This high growth rate can primarily be attributed to increased adoption by type 1 diabetes patients. Basal insulin pump therapy acts on slow-release mechanism, which is important for managing type 1 diabetes. All types of basal insulins are long-acting and mimic natural function of the pancreas. They accounted for a major share in type 1 diabetes patients.

Type Insights

Based on the type, the market is segmented into disposable and reusable patch pumps. Reusable insulin patch pump segment dominated the market in 2019, owing to high adoption and frequency of product launches. These devices are highly flexible and capable of delivering complex regimens of insulin to patients. Disposable insulin pumps are mechanical pumps and are also called simplified devices. Currently, V-Go by Valeritas and PAQ by CeQur dominate the market, as they have a strong presence in the U.S. as well as Europe.

Distribution Channel Insights

By distribution channel, the insulin patch pumps market is segmented into hospitals, retail pharmacies, private clinics, online pharmacies, and others. Hospitals segment dominated the market in 2019, owing to factors such as an increasing number of specialty hospital pharmacies and expansion of integrated delivery networks. Most of the first-time patch pump users tend to buy these from hospital pharmacies. Considering the recent shift in trend from traditional to automated insulin delivery solutions, the hospital pharmacy segment is expected to show significant growth rate over the forecast period.

The online pharmacies segment is expected to exhibit the fastest CAGR during the forecast period. The high growth rate of the segment can primarily be attributed to factors such as rising awareness about online pharmacies and increase in awareness campaigns by online pharmacies. Purchasing insulin patches through online pharmacies may involve risks such as wrong product delivery and improper usage.

Regional Insights

Regionally, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the market owing to availability of major brands of insulin patch pumps. Moreover, increasing healthcare expenditure and rising frequency of FDA approvals is also aiding growth in the region. For instance, in 2019, South Korean Company EoFlow received FDA approval for its newly designed patch pump-EOPatch-in the U.S.

Asia Pacific is expected to grow at the fastest pace due to factors such as rapidly growing diabetic population and increasing awareness about advanced digital diabetes management solutions in the region. In addition, increasing product launches and technological advancements in the field of insulin patch pumps are expected to aid regional growth.

Key Companies & Market Share Insights

Some of the leading players are Roche Diagnostics; Medtronic Plc; Valeritus; Insulet Corporation; Cellnovo Ltd; and CeQur. The major players are focusing on mergers & acquisitions, technological collaborations, and innovative product launches. For instance, in July 2018, Cequr purchased a certain asset from Calibra Medical-a subsidiary of Johnson & Johnson. These assets include latter’s wearable insulin delivery technology.

Insulin Patch Pumps Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels as well as provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the insulin patch pumps market report on the basis of delivery mode, product type, distribution channel, and region.

• Delivery Mode Outlook (Volume Units; Revenue, USD Million, 2016 - 2027)

  • Basal

  • Bolus

  • Basal & Bolus

• Product Type Outlook (Volume Units; Revenue, USD Million, 2016 - 2027)

  • Disposable

  • Reusable

• Distribution Channel Outlook (Volume Units; Revenue USD Million, 2016 - 2027)

  • Hospitals

  • Retail Pharmacies

  • Private Clinics

  • Online Pharmacies

  • Others

• Regional Outlook (Volume Units; Revenue, USD Million, 2016 - 2027)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Czech Republic

    • Russia

    • Poland

    • Turkey

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Vietnam

    • Philippines

    • Malaysia

    • Indonesia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Oman

    • Egypt